Cancer care: Long battle for affordable treatment

Advances in oncology have improved treatment options, but their benefits remain out of reach for many patients who cannot afford to complete the prescribed course. This is despite the recent decision to cap trade margins on 137 identified non-scheduled anti-cancer medicines, providing some relief, writes Afshan Yasmeen…

First reported by The Hindu 8 hr ago1 source

Read at The Hindu

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

The Hindu18:188 hr ago
Cancer care: Long battle for affordable treatment (opens The Hindu in a new tab)
Advances in oncology have improved treatment options, but their benefits remain out of reach for many patients who cannot afford to complete the prescribed course. This is despite the recent decision to cap trade margins on 137 identified non-scheduled…

Something wrong with how we've grouped or summarised this story? Report a problem